Arthritis patients’ often exaggerated fears about DMARDS are reflected in calls to a national medicines call centre, which show they mostly involve questions about perceived risks. An analysis of 1,547 DMARD-related calls to the NPS Medicines Line between 2002 and 2010, the top three enquiry types were about side-effects (25.2%), interactions (19.4%), and risk/benefit assessment ...
Unanswered DMARD concerns revealed in medicines helpline calls
By Mardi Chapman
9 Jul 2020